ddp4 inhibitors and glp 1 Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology Cardiovascular effects of DPP-4 inhibition:

A new secret shopper study published in JAMA has raised concerns about the oversight of online vendors prescribing glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the popular class of

The clinical trial, LIBERATE-1, will evaluate the safety, tolerance, and pharmacological effects of the

J., Yamada, Y., Tokuda, M., & Yada, T

Scientist-formulated, non-GMO, and made for consistent, everyday supplementation

Stopping semaglutide requires careful planning to minimize weight regain and metabolic disruption

Building Muscle While Taking GLP-1 Medications After Menopause: GLP-1 medications have changed the conversation around weight loss, diabete